Log In
Print
BCIQ
Print
Print this Print this
 

ISU302

  Manage Alerts
Collapse Summary General Information
Company Isu Abxis Co. Ltd.
DescriptionBiosimilar of cerezyme
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase III
Standard IndicationGaucher's disease
Indication DetailsTreat Gaucher's disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today